TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease.
Margarita M IvanovaJulia DaoLauren NollJacqueline FikryOzlem Goker-AlpanPublished in: Journal of clinical medicine (2021)
TRAP5b, RANKL, and RANKL/OPG elevation indicate osteoclast activation in GD. TRAP5b is a potential bone biomarker for GD with the ability to predict the progression of bone density abnormalities.